期刊文献+

铜绿假单胞菌296株临床分布及耐药性分析

Clinical distribution and resistance analysis of 296 strain pseudomonas aeruginosa
原文传递
导出
摘要 目的通过分析296株铜绿假单胞菌的分布和耐药情况,为医院感染控制及临床合理用药提供依据。方法应用回顾性调查方法分析沈阳医学院奉天医院2010-01-01-2010-12-01分离到的296株铜绿假单胞菌的临床分布及耐药性。结果 296株铜绿假单胞菌主要来源于痰液标本,主要集中于呼吸内科、ICU等科室;其耐药率最低的是头孢哌酮/舒巴坦和哌拉西林/他唑巴坦。结论铜绿假单胞菌是临床常见的病原菌,对哌拉西林/他唑巴坦和头孢哌酮/舒巴坦有较高的敏感性,但总的耐药率仍很高,可根据药敏结果合理选择用药。 Objeetive Io provide the basis for infection control and rational drug use in hospitals by analysis of 296 clinical isolates of Pseudomonas aeruginosa. Methods The clinical distribution and antimicrobial drug resistance of 296 strains Pseudomonas aeruginosa detached in Fengtian Hospital affiliated to Shenyang Medical College from 2010- 01-01--2010-12-01 were analysed by retrospective study. Results 296 isolated strains of Pseudomonas aeruginosa were mainly from the respiratory tract specimens, accounting for 74.0 % ,and mainly in respiratory department, ICU and neurosurgery departments,accounting for 52.7 %;the resistance rate of cefoperazone/sulbactam was the lowest 9. 1% and piperacillin/tazobactam 12.2 %, followed by levofloxacin 17.2 %, polymyxin B20.9 %. Conclusion Pseudomonas aeruginosa is a common clinical pathogenic bacteria sensitive to piperacillin/tazobactam and cefoperazone/ sulbaetam,but the overall resistance rate is still high. It should choose a single or several drugs in combination ac- cording to the the susceptibility results.
出处 《中国误诊学杂志》 CAS 2011年第30期7325-7326,共2页 Chinese Journal of Misdiagnostics
关键词 假单胞菌 铜绿/药物作用 抗药性 细菌 Pseudomonas aeruginosa/drug effects Drug Resistance, Bacterial
  • 相关文献

参考文献5

二级参考文献21

  • 1秦俊玲,韩呈武,王素兰,李春英,王路,林桂秋.10年临床感染细菌的病原学与常用抗生素的调查分析[J].中华医院感染学杂志,1996,6(4):243-245. 被引量:59
  • 2Ochs MM,Mc Cusker MP,Bains M,et al.Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic aminoacids[J].Antimicrob Agents Chemother,1999,43:1085-1090.
  • 3Li XZ,Zhang L,Srikumar R,et al.Beta-lactamase inhibitors are substrates for the multidrug effux pumps of Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,1998,42:399-403.
  • 4Nagino K,Kobayashi H.Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa[J].Clin Microdiol Infect,1997,(3):432-439.
  • 5Livermore DM,Winstanley TG,Shannon KP.Interpretative reading:recognizing the unusual and inferring resistance mechanisms from resistance phenotypes[J].J Antimicrob Chemot her,2001,48(Suppl 1):87-102.
  • 6Vedel G.Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test[J].J Antimicrob Chemother,2005,56 (4):657-664.
  • 7Paterson DL.The epidemiological profile of infections with multidrug-resistant Pseudonas aeruginosa and Acinetobacter species[J].Clin Infect Dis,2006,43(Suppl 2):S43-S48.
  • 8CLSI.Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement (M100-S17)[S].2007.
  • 9张凤凯,金少鸿,吴铨,张力.北京地区部分医院细菌对常用抗生素耐药性现状及变迁[J].中华医学杂志,1997,77(5):327-331. 被引量:99
  • 10缪竞智,张秀珍,张桂兰,孙春华.绿脓杆菌耐药性及抗生素的选择[J].中华医学杂志,1997,77(5):386-387. 被引量:20

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部